New Talcum Powder Lawsuit Trial Set for February

A new Johnson & Johnson's baby powder ovarian cancer lawsuit trial has been scheduled to take place before the City of St. Louis Circuit Court in February 2017.

Wednesday, June 29, 2016 - An order handed down by the City of St. Louis Circuit Court informed talcum powder ovarian cancer lawyers and the client involved in the pertinent case that a trial for their claim will begin on February 6, 2017. The trial will be the fourth heard before the court, with the third set to begin in September. The first two cases heard before the court resolved with $72 million and $55 million awards for the plaintiffs involved. These kinds of sums are causing many to believe Johnson & Johnson may soon consider a lump sum settlement to settle the more than 1,200 talcum powder cancer lawsuits currently pending around the country.

The trial will take place before a jury of 12, nine of which need to find in favor of either side in order for a decision to be made. The first two trials both met this threshold in favor of the plaintiffs, with the first winning just nine and the second carrying a larger margin. The second trial that was heard before the court was possibly more telling than the first, as the defense was able to select the plaintiff for the case. In the first trial, the talcum powder ovarian cancer lawyers representing the plaintiffs were able to chose a claim of their own to bring before a jury. In both cases Johnson & Johnson took large losses and will have to devise another way to fight the evidence the baby powder attorneys have mounted against them.

Thos talcum powder lawyers are backed by decades of medical research affirming that talcum powder and ovarian cancer are correlated, with some claiming the regular, genital use of talcum powder by women increases their risk for the disease by more than 30 percent. In addition to this, juries thus far have been significantly swayed by internal documents of Johnson & Johnson's that have been recovered by talcum powder attorneys representing the plaintiffs. These documents detail internal Johnson & Johnson doctors warning the company of the research being conducted into their talcum powder products and the consequences not acting on that information could have in their future.

Most of the talcum powder ovarian cancer lawsuits currently filed in the U.S. are pending in Missouri and New Jersey courts. The City of St. Louis Circuit Court has seen the majority of Johnson & Johnson's baby powder lawsuit trials thus far, and their docket is the only one in the country that currently has future trials scheduled to take place. There are more than 200 baby powder cancer lawsuits currently consolidated in New Jersey where Johnson & Johnson is consolidated. Barely over 100 talcum powder cancer lawsuits were included in the original multicounty consolidation that took place in late 2016 and have been picking up steadily since then.

The talcum powder attorneys involved in the February baby powder ovarian cancer lawsuit trial will be defending a total of six plaintiffs that filed a joint lawsuit against Johnson & Johnson claiming the company is responsible for damages related to their contraction of ovarian cancer. The first two trials only involved single plaintiffs.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.